Patent application number | Description | Published |
20100041717 | N-((3-BENZYL)-2,2-(BIS-PHENYL)-PROPAN-1-AMINE DERIVATIVES AS CETP INHIBITORS FOR THE TREATMENT OF ATHEROSCLEROSIS AND CARDIOVASCULAR DISEASES - Compounds of formula (Ia) and (Ib), wherein A, B, C, R | 02-18-2010 |
20100247534 | FUSED HETEROCYCLIC COMPOUNDS AS INHIBITORS OF POTASSIUM CHANNEL FUNCTION - A compound of formula I | 09-30-2010 |
20100267669 | HETEROCYCLIC CETP INHIBITORS - Compounds of formula Ia and Ib | 10-21-2010 |
20120094983 | ACYCLIC IKUR INHIBITORS - A compound of formula I | 04-19-2012 |
20120232068 | QUINAZOLINES AS POTASSIUM ION CHANNEL INHIBITORS - A compound of formula (I) wherein A, X, Y, Z, R | 09-13-2012 |
20120322761 | HETEROCYCLIC CETP INHIBITORS - Compounds of formula Ia and Ib | 12-20-2012 |
20130184279 | N-((3-BENZYL)-2,2-(BIS-PHENYL)-PROPAN-1-AMINE DERIVATIVES AS CETP INHIBITORS FOR THE TREATMENT OF ATHEROSCLEROSIS AND CARDIOVASCULAR DISEASES - Compounds of formula Ia and Ib | 07-18-2013 |
20130331564 | EPOTHILONE DERIVATIVES - The present invention relates to compounds of the formula | 12-12-2013 |
20140031345 | QUINAZOLINES AS POTASSIUM ION CHANNEL INHIBITORS - A compound of formula I | 01-30-2014 |
20140045811 | AMIDE, UREA OR SULFONE AMIDE LINKED BENZOTHIAZOLE INHIBITORS OF ENDOTHELIAL LIPASE - The present invention provides compounds of Formula (I): | 02-13-2014 |
20150080440 | EPOTHILONE DERIVATIVES - The present invention relates to compounds of the formula | 03-19-2015 |